Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price

Cell And Gene Therapy Market 2021 - By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders) And By Region, Opportunities And Strategies – Global Forecast To 2030

Cell and Gene Therapy market Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change

Starting Price : $4000.00 $2800.00 | Pages : 282 | Published : May 2021 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Cell And Gene Therapy Market Definition

The cell and gene therapy market consists of sales of cell and gene therapies by entities that produce them. Cell and gene therapy work with similar therapeutic goals, targeting DNA or RNA inside or outside the body. These therapies modify genetic material to improve functioning or fight diseases.  

Genes are the basic physical and functional unit of heredity, received from one’s parents. Genes act as a code for the creation of all proteins in a living organism. Gene therapy seeks to manipulate a patient’s cells to alter the biological property of cells for the treatment of an inherited or acquired disease. It works by several mechanisms, including replacing a disease-causing gene with a healthy copy of the gene, inactivating an ill-functioning disease-causing gene, or introducing a modified gene into the body to treat diseases.

Book your 30 minutes free consultation with our research experts

Contact Us

Cell And Gene Therapy Market Size

The global cell and gene therapy market reached a value of nearly $4,390.3 million in 2020, having increased at a compound annual growth rate (CAGR) of 25.5% since 2015. The market is expected to grow from $4,390.3 million in 2020 to $15,482.3 million in 2025 at a rate of 28.7%. The cell and gene therapy market is then expected to grow at a CAGR of 17.3% from 2025 and reach $34,317.9 million in 2030.  

Growth in the historic period in the cell and gene therapy market resulted from increase in investments in cell and gene therapies, growth in research and development, advances in cancer drug discovery, rise in public-private partnerships, strong economic growth in emerging markets, increased healthcare expenditure, and rising in pharmaceutical R&D expenditure. The cell and gene therapy market was restrained by inadequate reimbursements, challenges due to regulatory changes, low healthcare access, and limited number of treatment centers.

Going forward increasing prevalence of cancer and chronic diseases, rising geriatric population, rising geriatric population, rising focus on cell and gene therapy, and rise in healthcare expenditure will drive the growth in the cell and gene therapy market. Factors that could hinder the growth of the market in the future include high costs of therapy, stringent regulations, reimbursement challenges, and coronavirus pandemic.  

Cell And Gene Therapy Market Drivers  

The key drivers of the cell and gene therapy market include:

Increasing Prevalence of Cancer And Chronic Diseases

The rising prevalence of cancer and chronic cases across the globe is likely to contribute to the growth of the cell and gene therapy market during the forecast period. According to the Union for International Cancer Control (UICC)’s GLOBOCAN 2020: New Global Cancer Data published in December 2020, the global cancer burden has risen to 19.3 million cases and 10 million cancer deaths in 2020. Furthermore, according to the International Agency for Research on Cancer (IARC), globally 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease. As suggested by the new estimates, more than 50 million people are living within five years of a past cancer diagnosis. Socio-economic risk factors and the elderly population are a major cause for increasing cancer and chronic diseases, thereby driving the growth of the cell and gene therapy market.

Cell And Gene Therapy Market Restraints  

The key restraints on the cell and gene therapy market include:

Stringent Regulations

Stringent regulations imposed by regulators related to safety, efficacy, and quality are projected to act as a major challenge for players operating in the cell and gene therapy market. All medicines and treatments go through stringent testing in the lab (pre-clinical research) and in small groups of patients (clinical research). The European Medicines Agency (EMA) and The United States Food and Drug Administration (FDA) are the two main bodies regulating these novel therapies while getting them to market. The legislation on cell therapy in Europe is based on three directives Directive 2003/63/EC (which defines cell therapy products as clinical products and includes their specific requirements), Directive 2001/20/EC (which emphasizes that CTs are mandatory for such cell therapy products and describes the special requirements for approval of such trials),   Directive 2004/23/EC (which establishes the standard quality, donation safety, harvesting, tests, processing, preservation, storage, and distribution of human tissues and cells). The adverse events and patients’ deaths seen with therapies such as CAR-T cells in the early stages of their development are restricting these regulators from approvals of cell and gene therapies.

Cell And Gene Therapy Market Trends

Major trends influencing the cell and gene therapy market include:

Chimeric Antigen Receptor (CAR) T-Cell Therapy  

Chimeric antigen receptor (CAR) T-cell therapy is increasingly gaining traction. In (CAR) T -cell therapy, T cells are collected from the patient’s blood and are genetically engineered to produce modified receptors at their surface, known as chimeric antigen receptors (CARs). These modified T cells with special structures (receptors) are then reinfused into the patient. These modified receptors of T cell help in targeting the surface antigen of the cancer cell t and in turn result in the killing of tumor cells in patients. In 2020, the US-FDA approved Bristol-Myers Squibb`s two CAR-T cell therapies to treat lymphoma and multiple myeloma.  FDA approved CAR-T cells therapy treatments like Tisagenlecleucel for the treatment of B-cell precursor acute lymphoblastic leukemia (ALL) in children and Axicabtagene ciloleucel for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

Global Research Initiatives And Funding

Pharmaceutical companies and federal governments are increasingly working together in partnerships and collaborations to provide funding and implement incentive programs for the research and development (R&D) of cell and gene therapies. These partnerships provide financial and technical assistance across different clinical development phases to pharmaceutical companies. For instance, in June 2020, CSL Behring, a biotechnology company, and Seattle Children's Research Institute announced a strategic alliance to develop advanced stem cell gene therapy treatments for primary immunodeficiency diseases. In October 2019, the National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation pledge to invest $200 million over the next four years to speed the development of affordable gene therapies for human immunodeficiency virus (HIV) and sickle cell disease (SCD) on a global scale.  

Opportunities And Recommendations In The Cell And Gene Therapy Market

Opportunities – The top opportunities in the cell and gene therapy market segmented by product will arise in the gene therapy segment, which will gain $8,977.0 million of global annual sales by 2025. The top opportunities in the cell and gene therapy market segmented by application will arise in the oncology segment, which will gain $6,730.2 million of global annual sales by 2025. The cell and gene therapy market size will gain the most in the USA at $3,360.9 million.  

Recommendations – To take advantage of these opportunities, The Business Research Company recommends the cell and gene therapy companies to consider investing in the development of advanced therapies such as chimeric antigen receptor (CAR) T-cell therapy to offer patients with better treatment options, work on strategic alliances collaborations to integrate advanced technologies in the manufacturing of cell and gene therapy, expanding activities to emerging markets to gain market share, offer skimmed pricing to attract the users, leverage e-commerce tools to reach targeted people, among other strategies.

Cell And Gene Therapy Market Segmentation

The cell and gene therapy market is segmented by product, by application and by geography.
By Product-
The cell and gene therapy market is segmented by product into
    • a) Cell Therapy
    • b) Gene Therapy
The gene therapy market was the largest segment of the cell and gene therapy market segmented by product, accounting for 72.4% of the total in 2020. Going forward, the gene therapy segment is expected to be the fastest growing segment in the cell and gene therapy market segmented by product, at a CAGR of 30.8% during 2020-2025.
By Application-
The cell and gene therapy market is segmented by application into
    • a) Oncology
    • b) Neurological Disorders
    • c) Others
The oncology market was the largest segment of the cell and gene therapy market segmented by application, accounting for 64.6% of the total in 2020. Going forward, the neurological disorders segment is expected to be the fastest growing segment in the cell and gene therapy market segmented by application, at a CAGR of 30.7% during 2020-2025.
By Geography
The cell and gene therapy market is segmented by geography into
    • o North America
      • • USA
      • o Western Europe
      • • UK  
      • • Germany  
      • • France  
      o Asia Pacific
      • • China 
      • • Japan 
      • • India  
      • • Australia 
      • • Indonesia 
      • • South Korea 
      o Eastern Europe
      • • Russia
      o South America
      • • Brazil
      o Middle East
      o Africa
North America was the largest region in the global cell and gene therapy market, accounting for 49.8% of the total in 2020. It was followed by the Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the cell and gene therapy market will be the Middle East and South America where growth will be at CAGRs of 60.5% and 59.9% respectively. These will be followed by Asia Pacific and Eastern Europe, where the markets are expected to register CAGRs of 49.4% and 38.9% respectively.

Cell And Gene Therapy Competitive Landscape

Major Competitors In The Cell And Gene Therapy Market are:

  • Biogen Inc.
  • Novartis AG
  • Gilead Sciences
  • Ionis Pharmaceuticals, Inc.
  • Alnylam Pharmaceuticals, Inc.

    • Other Competitors In The Cell And Gene Therapy Market Include:

  • ArrowHead Pharmaceuticals Inc. 
  • Spark Therapeutics 
  • Bluebird Bio, Inc. 
  • RegenexBio 
  • Mesoblast Limited 
  • Biocon 
  • Cipla 
  • Stempeutics Research Pvt. Ltd. 
  • EdiGene, Inc. 
  • Immunochina 
  • Takara Bio 
  • Daiichi Sankyo Company 
  • Ultragenyx Pharmaceutical Inc 
  • Mitsubishi Tanabe Pharma 
  • Oxford Biomedica plc 
  • Santen Pharmaceutical Co. 
  • Therapeutic Innovation Australia 
  • Merck 
  • GenScript 
  • Cellular Biomedicine Group 
  • GE Healthcare 
  • inStem 
  • Lonza 
  • Nikon CeLL innovation Co. Ltd. 
  • Bristol-Myers Squibb 
  • Amgen 
  • Pfizer 
  • Albumedix Ltd 
  • Kite Pharma 
  • Catalent 
  • Oxford BioTherapeutics 
  • Freeline Therapeutics 
  • Avectas 
  • DiNAQOR AG 
  • Vivet Therapeutics 
  • Allergan 
  • Takeda Pharmaceutical 
  • PsiOxus Therapeutics 
  • Herantis Pharma Plc 
  • Biocad 
  • Celgene Corporation 
  • Johnson & Johnson 
  • F. Hoffmann-La Roche Ltd 
  • Eli Lilly and Company 
  • AstraZeneca 
  • Bayer AG 
  • Juno Therapeutics 
  • Allogene Therapeutics 
  • Regen BioPharma 
  • OncoSec Medical Incorporated 
  • Precision BioSciences  
  • Bellicum 
  • GlaxoSmithKline plc 
  • Middle East Gene Therapy Company 
  • DEVA  
  • Biotchpharma 
  • Gene Vector Technologies  
  • BrainStorm Cell Therapeutics 
  • Pluristem 
  • Sanofi 
  • Adcock Ingram 

      • Table Of Contents

      1. Cell And Gene Therapy Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Product

      6.3. Segmentation By Application

      7. Cell And Gene Therapy Market Characteristics

      7.1. Segmentation By Product

      7.1.1.Cell Therapy

      7.1.2.Gene Therapy

      7.2. Segmentation By Application

      7.2.1.Oncology

      7.2.2.Neurological Disorders

      7.2.3.Others

      8. Cell And Gene Therapy Market Trends And Strategies

      8.1. Chimeric Antigen Receptor (CAR) T-Cell Therapy

      8.2. Global Research Initiatives And Funding

      8.3. Integration Of Advanced Technologies In Cell And Gene Therapies

      8.4. Rising Focus On Gene Editing

      8.5. Increasing Partnerships And Acquisitions For Promoting Cell And Gene Therapies

      8.6. Increasing Number Of Pipeline Studies And Drug Development

      8.7. Growing Investments and Manufacturing Facility Expansion

      9. Impact Of COVID-19 On The Cell And Gene Therapy Market

      9.1. Introduction

      9.2. Impact On Manufacturing And Commercial Operations

      9.3. COVID-19 Impact On Treatment

      9.4. Drug Therapies

      9.5. Conclusion

      10. Global Cell And Gene Therapy Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      10.3.1. Drivers Of The Market 2020 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global Cell And Gene Therapy Market Segmentation

      11.1. Global Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.1.1. Gene Therapy

      11.1.2. Cell Therapy

      11.2. Global Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2.1. Oncology

      11.2.2. Neurological Disorders

      11.2.3. Others

      12. Cell And Gene Therapy Market, Regional And Country Analysis

      12.1. Global Cell And Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global Cell And Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13. Asia-Pacific Cell And Gene Therapy Market

      13.1. Asia-Pacific Cell And Gene Therapy Market Overview

      13.1.1. Region Information

      13.1.2. Impact of COVID-19

      13.1.3. Market Information

      13.1.4. Background Information

      13.1.5. Government Initiatives

      13.1.6. Regulations

      13.1.7. Regulatory Bodies

      13.1.8. Major Associations

      13.1.9. Taxes Levied

      13.1.10. Corporate Tax Structure

      13.1.11. Investments

      13.1.12. Major Companies

      13.2. Asia-Pacific Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3. Asia-Pacific Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.4. Asia-Pacific Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5. Asia-Pacific Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.6. Asia-Pacific Cell And Gene Therapy Market: Country Analysis

      13.7. China Cell And Gene Therapy Market

      13.8. China Cell And Gene Therapy Market Overview

      13.8.1. Country Information

      13.8.2. Impact of COVID-19

      13.8.3. Market Information

      13.8.4. Background Information

      13.8.5. Government Initiatives

      13.8.6. Regulations

      13.8.7. Regulatory Bodies

      13.8.8. Major Associations

      13.8.9. Taxes Levied

      13.8.10. Corporate Tax Structure

      13.8.11. Investments

      13.8.12. Major Companies

      13.9. China Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.10. China Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.11. China Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.12. China Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.13. India Cell And Gene Therapy Market

      13.14. India Cell And Gene Therapy Market Overview

      13.14.1. Country Information

      13.14.2. Impact of COVID-19

      13.14.3. Market Information

      13.14.4. Background Information

      13.14.5. Government Initiatives

      13.14.6. Regulations

      13.14.7. Regulatory Bodies

      13.14.8. Major Associations

      13.14.9. Tax Levied

      13.14.10.   Corporate Tax Structure

      13.14.11.   Investments

      13.14.12.   Major Companies

      13.15. India Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.16. India Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.17. India Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.18. India Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.19. Japan Cell And Gene Therapy Market

      13.20. Japan Cell And Gene Therapy Market Overview

      13.20.1. Country Information

      13.20.2. Impact of COVID-19

      13.20.3. Market Information

      13.20.4. Background Information

      13.20.5. Government Initiatives

      13.20.6. Regulations

      13.20.7. Regulatory Bodies

      13.20.8. Major Associations

      13.20.9. Tax Levied

      13.20.10.   Corporate Tax Structure

      13.20.11.   Investments

      13.20.12.   Major Companies

      13.21. Japan Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.22. Japan Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.23. Japan Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.24. Japan Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.25. Australia Cell And Gene Therapy Market

      13.26. Australia Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.27. Australia Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.28. Australia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.29. Australia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.30. Indonesia Cell And Gene Therapy Market

      13.31. Indonesia Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.32. Indonesia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.33. Indonesia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.34. South Korea Cell And Gene Therapy Market

      13.35. South Korea Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.36. South Korea Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.37. South Korea Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.38. South Korea Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe Cell And Gene Therapy Market

      14.1. Western Europe Cell And Gene Therapy Market Overview

      14.1.1. Region Information

      14.1.2. Impact Of COVID-19

      14.1.3. Market Information

      14.1.4. Background Information

      14.1.5. Government Initiatives

      14.1.6. Regulations

      14.1.7. Regulatory Bodies

      14.1.8. Major Associations

      14.1.9. Taxes Levied

      14.1.10. Corporate Tax Structure

      14.1.11. Investments

      14.1.12. Major Companies

      14.2. Western Europe Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3. Western Europe Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.4. Western Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.6. Western Europe Cell And Gene Therapy Market: Country Analysis

      14.7. UK Cell And Gene Therapy Market

      14.8. UK Cell And Gene Therapy Market Overview

      14.8.1. Country Information

      14.8.2. Impact Of COVID-19

      14.8.3. Market Information

      14.8.4. Background Information

      14.8.5. Government Initiatives

      14.8.6. Regulations

      14.8.7. Regulatory Bodies

      14.8.8. Major Associations

      14.8.9. Taxes Levied

      14.8.10. Corporate Tax Structure

      14.8.11. Investments

      14.8.12. Major Companies

      14.9. UK Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.10. UK Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.11. UK Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.12. UK Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.13. Germany Cell And Gene Therapy Market

      14.14. Germany Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.15. Germany Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.16. Germany Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.17. Germany Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.18. France Cell And Gene Therapy Market

      14.19. France Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.20. France Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.21. France Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.22. France Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe Cell And Gene Therapy Market

      15.1. Eastern Europe Cell And Gene Therapy Market Overview

      15.1.1. Region Information

      15.1.2. Impact Of COVID-19

      15.1.3. Market Information

      15.1.4. Background Information

      15.1.5. Government Initiatives

      15.1.6. Regulations

      15.1.7. Regulatory Bodies

      15.1.8. Major Associations

      15.1.9. Taxes Levied

      15.1.10. Corporate Tax Structure

      15.1.11. Investments

      15.1.12. Major Companies

      15.2. Eastern Europe Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.3. Eastern Europe Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.4. Eastern Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5. Eastern Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.6. Eastern Europe Cell And Gene Therapy Market: Country Analysis

      15.7. Russia Cell And Gene Therapy Market

      15.8. Russia Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.9. Russia Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.10. Russia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.11. Russia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America Cell And Gene Therapy Market

      16.1. North America Cell And Gene Therapy Market Overview

      16.1.1. Region Information

      16.1.2. COVID-19 Impact

      16.1.3. Market Information

      16.1.4. Background Information

      16.1.5. Regulations

      16.1.6. Regulatory Bodies

      16.1.7. Major Associations

      16.1.8. Taxes Levied

      16.1.9. Corporate Tax Structure

      16.1.10. Investments

      16.1.11. Major Companies

      16.2. North America Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3. North America Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.4. North America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.6. North America Cell And Gene Therapy Market: Country Analysis

      16.7. USA Cell And Gene Therapy Market

      16.8. USA Cell And Gene Therapy Market Overview

      16.8.1. Country Information

      16.8.2. COVID-19 Impact

      16.8.3. Market Information

      16.8.4. Background Information

      16.8.5. Government Initiatives

      16.8.6. Regulations

      16.8.7. Regulatory Bodies

      16.8.8. Major Associations

      16.8.9. Taxes Levied

      16.8.10. Corporate Tax Structure

      16.8.11. Investments

      16.8.12. Major Companies

      16.9. USA Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.10. USA Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.11. USA Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.12. USA Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America Cell And Gene Therapy Market

      17.1. South America Cell And Gene Therapy Market Overview

      17.1.1. Region Information

      17.1.2. COVID-19 Impact

      17.1.3. Market Information

      17.1.4. Background Information

      17.1.5. Government Initiatives

      17.1.6. Regulations

      17.1.7. Regulatory Bodies

      17.1.8. Major Associations

      17.1.9. Taxes Levied

      17.1.10. Corporate Tax Structure

      17.1.11. Investments

      17.1.12. Major Companies

      17.2. South America Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. South America Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.4. South America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.6. South America Cell And Gene Therapy Market: Country Analysis

      17.7. Brazil Cell And Gene Therapy Market

      17.8. Brazil Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.9. Brazil Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.10. Brazil Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.11. Brazil Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East Cell And Gene Therapy Market

      18.1. Middle East Cell And Gene Therapy Market Overview

      18.1.1. Region Information

      18.1.2. COVID-19 Impact

      18.1.3. Market Information

      18.1.4. Background Information

      18.1.5. Government Initiatives

      18.1.6. Regulations

      18.1.7. Regulatory Bodies

      18.1.8. Major Associations

      18.1.9. Taxes levied

      18.1.10. Corporate Tax Structure

      18.1.11. Investments

      18.1.12. Major Companies

      18.2. Middle East Cell And Gene Therapy Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3. Middle East Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.4. Middle East Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Middle East Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa Cell And Gene Therapy Market

      19.1. Africa Cell And Gene Therapy Market Overview

      19.1.1. Regional Information

      19.1.2. COVID-19 Impact

      19.1.3. Background Information

      19.1.4. Government Initiatives

      19.1.5. Regulations

      19.1.6. Regulatory Bodies

      19.1.7. Associations

      19.1.8. Taxes levied

      19.1.9. Corporate Tax Structure

      19.1.10. Investments

      19.1.11. Major Companies

      19.2. Africa Cell And Gene Therapy Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.3. Africa Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.4. Africa Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. Global Cell And Gene Therapy Market Competitive Landscape

      20.1. Company Profiles

      20.2. Biogen Inc.

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Novartis AG

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Gilead Sciences, Inc.

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Ionis Pharmaceuticals, Inc.

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. Alnylam Pharmaceuticals, Inc.

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Key Mergers And Acquisitions In The Cell And Gene Therapy Market

      21.1. Thermo Fisher Scientific Acquired Viral Vector Business From Novasep for $875.76 million

      21.2. Astellas Acquired Audentes Therapeutics for $3 billion

      21.3. Roche Acquired Spark Therapeutics Incorporated for $4.8 billion

      21.4. Vertex Acquired Semma Therapeutics for $950 million

      21.5. Bayer Acquired BlueRock Therapeutics for $1 billion

      21.6. Biogen Acquired Nightstar Therapeutics for $800 million

      21.7. Catalent Acquired Paragon Bioservices Incorporated for $1.2 billion

      21.8. Novartis Acquired AveXis for $8.7 billion

      22. Cell And Gene Therapy Market Opportunities And Strategies

      22.1. Global Cell And Gene Therapy Market In 2025 – Countries Offering Most New Opportunities

      22.2. Global Cell And Gene Therapy Market In 2025 – Segments Offering Most New Opportunities

      22.3. Global Cell And Gene Therapy Market In 2025 – Growth Strategies

      22.3.1. Market Trend Based Strategies

      22.3.2. Competitor Strategies

      23. Cell And Gene Therapy Market, Conclusions And Recommendations

      23.1. Conclusions

      23.2. Recommendations

      23.2.1. Product

      23.2.2. Price

      23.2.3. Place

      23.2.4. Promotion

      23.2.5. People

      24. Appendix

      24.1. Market Data Sources

      24.2. Research Methodology

      24.3. Currencies

      24.4. Research Inquiries

      24.5. The Business Research Company

      24.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global Cell And Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global Cell And Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global Cell And Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global Cell And Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Asia-Pacific Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 12: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 13: Asia Pacific Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 14: Asia-Pacific Cell and Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
    • Table 15: Asia-Pacific Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 16: Asia-Pacific Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 17: Asia-Pacific Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 18: Asia-Pacific Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 19: Asia-Pacific Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 20: Asia-Pacific Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 21: China Cell And Gene Therapy Market, Healthcare Expenditure, 2015-2019, $ Billion
    • Table 22: China GDP Per Capita, 2015-2020, $
    • Table 23: China Cell And Gene Therapy Market, Population By Age Group, 2015-2023, Thousands
    • Table 24: China Cell And Gene Therapy Market, Biologics Market Size, 2015-2025, $ Billion
    • Table 25: China Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 26: China Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 27: China Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 28: China Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 29: China Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 30: China Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 31: India Cell And Gene Therapy Market, Healthcare Expenditure, 2015-2019, $ Billion
    • Table 32: India GDP Per Capita, 2015-2020, $
    • Table 33: India Cell And Gene Therapy Market, Population By Age Group, 2015-2023, Thousands
    • Table 34: India Cell And Gene Therapy Market, Biologics Market Size, 2015-2025, $ Billion
    • Table 35: India Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 36: India Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 37: India Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 38: India Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 39: India Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 40: India Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 41: Japan Cell And Gene Therapy Market, Healthcare Expenditure, 2015-2019, $ Billion
    • Table 42: Japan GDP Per Capita, 2015-2020, $
    • Table 43: Japan Cell And Gene Therapy Market, Population By Age Group, 2015-2023, Thousands
    • Table 44: Japan Cell And Gene Therapy Market, Biologics Market Size, 2015-2025, $ Billion
    • Table 45: Japan Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 46: Japan Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 47: Japan Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 48: Japan Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 49: Japan Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 50: Japan Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 51: Australia Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 52: Australia Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 53: Australia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 54: Australia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 55: Australia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 56: Australia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 57: Indonesia Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 58: Indonesia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 59: Indonesia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 60: Indonesia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 61: Indonesia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 62: South Korea Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 63: South Korea Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 64: South Korea Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 65: South Korea Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 66: South Korea Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 67: South Korea Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 68: Western Europe Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 69: Western Europe GDP Per Capita, 2015-2020, $
    • Table 70: Western Europe Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 71: Western Europe Cell And Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
    • Table 72: Western Europe Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 73: Western Europe Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 74: Western Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 75: Western Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 76: Western Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 77: Western Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 78: UK Cell And Gene Therapy Market, Healthcare Expenditure, 2015-2019, $ Billion
    • Table 79: UK GDP Per Capita, 2015-2020, $
    • Table 80: UK Cell And Gene Therapy Market, Population By Age Group, 2015-2023, Thousands
    • Table 81: UK Cell And Gene Therapy Market, Biologics Market Size, 2015-2025, $ Billion
    • Table 82: UK Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 83: UK Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 84: UK Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 85: UK Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 86: UK Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 87: UK Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 88: Germany Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 89: Germany Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 90: Germany Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 91: Germany Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 92: Germany Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 93: Germany Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 94: France Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 95: France Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 96: France Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 97: France Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 98: France Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 99: France Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 100: Eastern Europe Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 101: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 102: Eastern Europe Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 103: Eastern Europe Cell And Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
    • Table 104: Eastern Europe Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 105: Eastern Europe Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 106: Eastern Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 107: Eastern Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 108: Eastern Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 109: Eastern Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 110: Russia Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 111: Russia Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 112: Russia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 113: Russia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 114: Russia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 115: Russia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 116: North America Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 117: North America GDP Per Capita, 2015-2020, $
    • Table 118: North America Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 119: North America Cell And Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
    • Table 120: North America Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 121: North America Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 122: North America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 123: North America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 124: North America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 125: North America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 126: USA Cell And Gene Therapy Market, Healthcare Expenditure, 2015-2019, $ Billion
    • Table 127: USA GDP Per Capita, 2015-2020, $
    • Table 128: USA Cell And Gene Therapy Market, Population By Age Group, 2015-2023, Thousands
    • Table 129: USA Cell And Gene Therapy Market, Biologics Market Size, 2015-2025, $ Billion
    • Table 130: USA Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 131: USA Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 132: USA Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 133: USA Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 134: USA Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 135: USA Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 136: South America Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 137: South America GDP Per Capita, 2015-2020, $
    • Table 138: South America Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 139: South America Cell And Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
    • Table 140: South America Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 141: South America Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 142: South America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 143: South America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 144: South America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 145: South America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 146: Brazil Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 147: Brazil Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 148: Brazil Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 149: Brazil Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 150: Brazil Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 151: Brazil Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 152: Middle East Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 153: Middle East GDP Per Capita, 2015-2020, $
    • Table 154: Middle East Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 155: Middle East Cell And Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
    • Table 156: Middle East Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Table 157: Middle East Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 158: Middle East Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 159: Middle East Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 160: Middle East Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 161: Middle East Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 162: Africa Cell And Gene Therapy Market, Healthcare Expenditure, By Country, 2015-2019, $ Billion
    • Table 163: Africa GDP Per Capita, 2015-2020, $
    • Table 164: Africa Cell And Gene Therapy Market, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 165: Africa Cell And Gene Therapy Market, Biologics Market Size, By Country, 2015-2025, $ Billion
    • Table 166: Africa Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 167: Africa Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 168: Africa Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 169: Africa Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 170: Africa Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 171: Global Cell And Gene Therapy Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
    • Table 172: Biogen Inc. – Financial Performance, 2015 – 2019, $ Million
    • Table 173: Novartis AG – Financial Performance, 2016 - 2020, $ Billion
    • Table 174: Gilead Sciences, Inc. –  Financial Performance, 2015 – 2019, $ Billion
    • Table 175: Ionis Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million
    • Table 176: Alnylam Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million
    • Table 177: Global Cell And Gene Therapy Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 178: Global Cell And Gene Therapy Market Size Gain ($ Million), Segmentation By Product, 2020 – 2025
    • Table 179: Global Cell And Gene Therapy Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025
    • Table 180: Cell And Gene Therapy - Market Data Sources

    List Of Figures

      Figure 1: Global Cell And Gene Therapy Market Segmentation By Product
    • Figure 2: Global Cell And Gene Therapy Market Segmentation By Application
    • Figure 3: Global Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 4: Global Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 5: Global Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 6: Global Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 7: Global Cell And Gene Therapy Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 8: Global Cell And Gene Therapy Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Asia-Pacific Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 10: Asia-Pacific Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 11: Asia-Pacific Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 12: Asia-Pacific Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 13: China Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 14: China Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 15: China Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 16: China Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 17: India Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 18: India Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 19: India Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 20: India Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 21: Japan Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 22: Japan Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 23: Japan Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 24: Japan Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 25: Australia Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 26: Australia Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 27: Australia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 28: Australia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 29: Indonesia Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 30: Indonesia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 31: Indonesia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 32: South Korea Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 33: South Korea Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 34: South Korea Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 35: South Korea Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 36: Western Europe Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 37: Western Europe Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 38: Western Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 39: Western Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 40: UK Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 41: UK Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 42: UK Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 43: UK Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 44: Germany Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 45: Germany Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 46: Germany Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 47: Germany Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 48: France Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 49: France Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 50: France Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: France Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 52: Eastern Europe Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 53: Eastern Europe Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 54: Eastern Europe Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 55: Eastern Europe Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 56: Russia Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 57: Russia Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 58: Russia Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 59: Russia Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 60: North America Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 61: North America Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 62: North America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 63: North America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 64: USA Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 65: USA Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 66: USA Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 67: USA Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 68: South America Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 69: South America Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 70: South America Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 71: South America Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 72: Brazil Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 73: Brazil Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 74: Brazil Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 75: Brazil Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 76: Middle East Cell And Gene Therapy Market, Historic, 2015 – 2020, $ Million
    • Figure 77: Middle East Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 78: Middle East Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 79: Middle East Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 80: Africa Cell And Gene Therapy Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 81: Africa Cell And Gene Therapy Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 82: Africa Cell And Gene Therapy Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 83: Global Cell And Gene Therapy Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
    • Figure 84: Biogen Inc. – Financial Performance, 2015 – 2019, $ Million
    • Figure 85: Novartis AG – Financial Performance, 2016 - 2020, $ Billion
    • Figure 86: Gilead Sciences, Inc. – Financial Performance, 2015 – 2019, $ Billion
    • Figure 87: Ionis Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million
    • Figure 88: Alnylam Pharmaceuticals, Inc. – Financial Performance, 2015 – 2019, $ Million

    The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

    Read More

    The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

    Read More

    Global Anticoagulants Market 2022 – Market Opportunities And Strategies

    Read More

    What Is The Compression Therapy Market Overview In 2022?

    Read More

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

    Read More

    3D Cell Culture Technologies Global Market Report 2024 – By Type (Scaffold-based, Scaffold-free, 3D Bioreactors), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine), By End Users (Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Cell Culture Consumables And Equipment Global Market Report 2024 – By Product (Consumables, Instruments), By Application (Vaccination, Toxicity testing, Cancer Research, Drug Screening and Development, Recombinant Products, Stem cell technology, Regenerative Medicine, Other End Users), By End User (Industrial, Biotechnology, Agriculture, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Stem Cell/Cord Blood Banking Global Market Report 2024 – By Cell Type (Adult Stem Cells, Umbilical Cord Blood Stem Cells, Embryonic Stem Cells), By Service (Collection, Processing, Analysis, Storage), By Bank Type (Public, Private), By Application (Leukemia, Anemia, Thalassemia, Autism, Cerebral Palsy, Diabetes, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Cell Culture Global Market Report 2024 – By Type (Primary Cell Culture, Secondary Cell Culture, Cell Line), By Media (Natural, Artificial), By Applications (Stem Cell Technologies, Cancer Research, Biopharmaceutical, Tissue Engineering & Regenerative Medicine, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Cellular Immunotherapy Global Market Report 2024 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Cell and Gene Therapy Global Market Report 2024 – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Cell Therapy Global Market Report 2024 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Cell Therapy Technologies Global Market Report 2024 – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cells), By Process (Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control), By End User (Life Science Companies, Research Institutes And Cell Banks) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Frequently Asked Questions

    What is the definition of the cell and gene therapy market market?

    The cell and gene therapy market consists of sales of cell and gene therapies by entities that produce them. Cell and gene therapy work with similar therapeutic goals, targeting DNA or RNA inside or outside the body. These therapies modify genetic material to improve functioning or fight diseases.   request a sample here

    How will the cell and gene therapy market market drivers and restraints affect cell and gene therapy market market dynamics? What forces will shape the cell and gene therapy market industry going forward?

    The cell and gene therapy market growth is aided by increasing prevalence of cancer and chronic diseases. However, some cell and gene therapy market restraints include stringent regulations request a sample here

    What is the forecast market size of the cell and gene therapy market market?

    The cell and gene therapy market forecast is expected to reach $34,317.9 million in 2030 at a compound annual growth rate of 17.3%. request a sample here

    How is the cell and gene therapy market market segmented?

    The global cell and gene therapy market is segmented -
    1) By Product: Cell Therapy, Gene Therapy
    2) By Application: Oncology, Neurological Disorders, Others     request a sample here

    Which region has largest share, and what is the market size and growth by geography according to the cell and gene therapy market global market report?

    For this and further detailed insights on the market, request a sample here. request a sample here.

    Who are the key players of the global cell and gene therapy market market?

    Top competitors in the cell and gene therapy market include Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc. request a sample here.

    What are the key trends in the global cell and gene therapy market market?

    Major trends influencing the cell and gene therapy market include chimeric antigen receptor (car) t-cell therapy request a sample here.

    What are the major opportunities in the cell and gene therapy market market and the approaches companies can take to take advantage of them?

    For this and further detailed insights on the market, request a sample here. request a sample here.

    How does the cell and gene therapy market market relate to the overall economy and other similar markets?

    request a sample here.

    request a sample here.

    request a sample here.